Drug Name | IUPAC Name | Classification (KD Tripathi) | Drug Application | Receptors | Dosage Form | Route of Administration | Adverse Reactions | Appearance | Solubility | pKa Value | Functional Groups |
---|---|---|---|---|---|---|---|---|---|---|---|
Levothyroxine | Sodium (2S)-2-(4-hydroxy-3-iodophenyl)propanoate | Thyroid hormone Subclass: Synthetic thyroxine |
Hypothyroidism | Thyroid hormone receptor | Tablet (25 mcg, 50 mcg, 100 mcg, 200 mcg) Oral solution (100 mcg/mL) |
Oral | Palpitations, weight loss, sweating | White to off-white crystalline powder | Freely soluble in water | pKa = 4.7 | Phenol, iodine, ether |
Metformin | 1,1-Dimethylbiguanide | Antidiabetic Subclass: Biguanide |
Type 2 diabetes mellitus | AMP-activated protein kinase (AMPK) | Tablet (500 mg, 850 mg, 1000 mg) Extended-release tablet (500 mg, 750 mg, 1000 mg) |
Oral | Gastrointestinal upset, lactic acidosis | White crystalline powder | Soluble in water | pKa = 12.4 | Biguanide |
Insulin | Insulin (human) | Antidiabetic Subclass: Insulin |
Diabetes mellitus | Insulin receptor | Injection (multiple formulations) | Subcutaneous | Hypoglycemia, weight gain, allergic reactions | Clear or cloudy solution | Soluble in water | N/A | Protein |
Prednisone | 6-alpha-methylprednisolone | Glucocorticoid Subclass: Corticosteroid |
Inflammatory conditions, autoimmune diseases | Glucocorticoid receptor | Tablet (1 mg, 5 mg, 10 mg, 20 mg, 50 mg) Oral solution (5 mg/5 mL) |
Oral | Osteoporosis, weight gain, hypertension | White crystalline powder | Freely soluble in water | pKa = 13.5 | Ketone, alcohol, steroid |
Estradiol | 1,3,5(10)-estratriene-3,17-diol | Estrogen Subclass: Synthetic estrogen |
Hormone replacement therapy, contraception | Estrogen receptor | Tablet (0.5 mg, 1 mg) Patch (various dosages) |
Oral, transdermal | Nausea, headache, breast tenderness | White to off-white crystalline powder | Soluble in ethanol | pKa = 10.0 | Phenol, alcohol, steroid |
Glibenclamide | 1-((4-(chlorobenzamido)phenyl)sulfonyl)-3-((4-methylphenyl)ethyl)urea | Antidiabetic Subclass: Sulfonylurea |
Type 2 diabetes mellitus | Insulin receptor | Tablet (2.5 mg, 5 mg) | Oral | Hypoglycemia, weight gain | White crystalline powder | Soluble in water | pKa = 5.8 | Sulfonylurea, amide |
Sitagliptin | (3R)-3-amino-4-(trifluoromethyl)-1-[(3-hydroxy-1-oxo-2-azaspiro[4.5]dec-2-yl)methyl]piperidine-2-carbonitrile | Antidiabetic Subclass: DPP-4 inhibitor |
Type 2 diabetes mellitus | Dipeptidyl peptidase-4 (DPP-4) | Tablet (25 mg, 50 mg, 100 mg) | Oral | Nausea, headache | White to off-white powder | Soluble in water | pKa = 9.3 | Amines, nitriles |
Rosiglitazone | (Z)-5-[4-(2-(4-(trifluoromethyl)phenyl)thiazol-2-yl)phenyl]methyl-2,4-thiazolidinedione | Antidiabetic Subclass: Thiazolidinedione |
Type 2 diabetes mellitus | Peroxisome proliferator-activated receptor gamma (PPAR-γ) | Tablet (2 mg, 4 mg, 8 mg) | Oral | Edema, weight gain | White crystalline powder | Soluble in DMSO | pKa = 5.5 | Thiazolidinedione |
Liothyronine | 3,3',5-triiodo-L-thyronine | Thyroid hormone Subclass: Synthetic T3 |
Hypothyroidism | Thyroid hormone receptor | Tablet (5 mcg, 25 mcg) | Oral | Palpitations, sweating | White to off-white powder | Freely soluble in water | pKa = 7.3 | Iodine, phenol |
Hydrocortisone | Pregn-4-ene-3,20-dione,21-hydroxy- | Glucocorticoid Subclass: Corticosteroid |
Adrenal insufficiency, inflammatory conditions | Glucocorticoid receptor | Tablet (5 mg, 10 mg, 20 mg) Injection |
Oral, IV | Osteoporosis, hypertension | White to off-white powder | Soluble in ethanol | pKa = 10.5 | Ketone, alcohol, steroid |
Desmopressin | 1-Desamino-8-D-arginine vasopressin | Antidiuretic Subclass: Synthetic analog of vasopressin |
Diabetes insipidus | Vasopressin receptor | Injection, nasal spray | Subcutaneous, intranasal | Headache, nausea | White powder | Soluble in water | pKa = 6.5 | Amines |
Somatropin | Recombinant human growth hormone | Growth hormone Subclass: Recombinant hormone |
Growth hormone deficiency | Growth hormone receptor | Injection | Subcutaneous | Injection site reactions | White lyophilized powder | Soluble in water | N/A | Protein |
Octreotide | Sandostatin | Antisecretory Subclass: Somatostatin analog |
Acromegaly, carcinoid syndrome | Somatostatin receptor | Injection | Subcutaneous | Nausea, abdominal pain | White to off-white powder | Soluble in water | N/A | Peptide |
Leuprolide | Leuprolide acetate | Gonadotropin-releasing hormone (GnRH) analog Subclass: Peptide |
Prostate cancer, endometriosis | GnRH receptor | Injection | Subcutaneous | Hot flashes, weight gain | White powder | Soluble in water | N/A | Peptide |
Fludrocortisone | 21-Fluoropregn-4-ene-3,20-dione | Mineralocorticoid Subclass: Corticosteroid |
Adrenal insufficiency | Mineralocorticoid receptor | Tablet (0.1 mg) | Oral | Hypertension, hypokalemia | White powder | Soluble in alcohol | pKa = 15.0 | Ketone, alcohol, steroid |
Levonorgestrel | (13S)-13-Ethyl-17-hydroxy-18-methyl-19-norpregna-4, 15-diene-3,20-dione | Progestin Subclass: Synthetic progestin |
Contraception | Progesterone receptor | Tablet (0.75 mg, 1.5 mg) | Oral | Irregular menstrual bleeding | White to off-white powder | Soluble in ethanol | pKa = 10.4 | Phenol, ketone, steroid |
Clomiphene | Clomifene citrate | Estrogen receptor modulator Subclass: Selective estrogen receptor modulator (SERM) |
Infertility | Estrogen receptor | Tablet (50 mg) | Oral | Hot flashes, multiple births | White powder | Soluble in ethanol | pKa = 8.0 | Aromatics, ether |
Dexamethasone | 9-fluoro-11β,17-dihydroxy-16α-methyl-pregna-1,4-diene-3,20-dione | Glucocorticoid Subclass: Corticosteroid |
Inflammation, allergies | Glucocorticoid receptor | Tablet (0.5 mg, 0.75 mg, 1 mg, 2 mg) | Oral | Osteoporosis, hypertension | White crystalline powder | Soluble in alcohol | pKa = 10.5 | Ketone, alcohol, steroid |
Calcitriol | 1,25-Dihydroxycholecalciferol | Vitamin D analog Subclass: Active form of vitamin D |
Hypoparathyroidism, rickets | Vitamin D receptor | Capsule (0.25 mcg, 0.5 mcg) | Oral | Hypercalcemia | Yellow to orange powder | Soluble in alcohol, oil | pKa = 7.4 | Steroid |